• Users Online: 120
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

EDITORIAL

Biologics in psoriasis: Indian experience

Parasramani Shrichand G, Pillai Jisha

Year : 2019| Volume: 5| Issue : 1 | Page no: 1-5

   This article has been cited by
 
1 An Open-Label, Randomized, Prospective, Comparative, Three-Arm Clinical Trial to Evaluate the Safety and Effectiveness of Apremilast with Three Different Titration Methods in Patients with Chronic Plaque Psoriasis in India
Vishalakshi Viswanath, Pradnya Joshi, Prakash Lawate, Dakshata Tare, Dhiraj Dhoot, Namrata Mahadkar, Hanmant Barkate
Psoriasis: Targets and Therapy. 2022; Volume 12: 53
[Pubmed]  [Google Scholar] [DOI]
2 Portraying molecular modulation and therapeutic aspects of psoriasis: Retrospection and current status
Kajal Sharma,Shalki Choudhary,Om Silakari
Journal of Molecular Structure. 2021; : 130770
[Pubmed]  [Google Scholar] [DOI]
3 The Use of Apremilast in Psoriasis: An Indian Perspective on Real-World Scenarios
Murlidhar Rajagopalan,Sunil Dogra,Abir Saraswat,Sachin Varma,Pravin Banodkar
Psoriasis: Targets and Therapy. 2021; Volume 11: 109
[Pubmed]  [Google Scholar] [DOI]

 

Read this article